Navigation Links
InVitria to Present at WilBio's International Cell Engineering Meeting
Date:11/4/2008

Innovator of animal free and defined cell culture media components will feature its productivity maximizing product at WilBio Dec. 2-4, 2008.

Fort Collins, CO (PRWEB) November 4, 2008 -- InVitria's Cellastim (recombinant albumin), which has been shown to outperform animal derived albumins in cell culture, will be featured at the 2nd International Cell Engineering Meeting hosted by the Williamsburg BioProcessing Foundation (WilBio) on December 2-4 in Santa Barbara, CA (US).

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present results from the recently completed study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO" at the 2008 WilBio meeting, which is centered on optimizing cell productivity, stability and safety.

Data from the study showed that Cellastim is a robust supplement for CHO media and can improve both the growth kinetics and productivity of CHO cell lines. Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in an average 50% increase in productivity across a variety of chemically defined cell culture media.

"InVitria's Cellastim is a safe and effective alternative for improving cell culture performance," said InVitria President Scott Deeter. "WilBio's 2008 Cell Engineering Meeting will be focused on cell optimization, stability and safety--all of which are a good match for the benefits delivered by Cellastim in cell culture media."

About InVitria
InVitria has developed defined and animal free cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info@InVitria.com
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/Cellastim/cellproductivity/prweb1570394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Jennerex To Present at Rodman & Renshaw 10th Annual Healthcare Conference
2. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
3. Alexion to Present at Investor Conferences
4. IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference
5. Jazz Pharmaceuticals to Present at Investor Conferences
6. Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference
7. XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11
8. The Quantum Group Inc. To Present at Paulson Investments 31st Annual Westergaard Conference
9. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
10. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
11. BD to Present at Investor Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating its ... location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. There ... TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, DDS, ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... Cosmetic dentistry is a fast-growing field as more patients are discovering the many different ... more about the options currently available to them and which ones might work for ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. ... Potter -- are proud of the recent release of their 2014 in vitro fertilization ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology: